Atlas Trials

A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.

Clinical trial NCT02667236 · COMPLETED

Trial details

NCT number
NCT02667236
Sponsor
Aclaris Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Seborrheic Keratosis
Start date
2016-01-01
Primary completion
2016-10-01
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.